CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 78 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,192,080 | $6,545,000 | 3.19% |
| COURAGE CAPITAL MANAGEMENT LLC | 200,000 | $1,098,000 | 0.74% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 174,512 | $958,000 | 0.06% |
| Family Management Corp | 14,000 | $77,000 | 0.05% |
| EAM Investors, LLC | 62,752 | $345,000 | 0.05% |
| FNY Managed Accounts LLC | 4,400 | $24,000 | 0.03% |
| ACADIAN ASSET MANAGEMENT LLC | 1,090,397 | $5,988,000 | 0.03% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $121,000 | 0.02% |
| Alambic Investment Management, L.P. | 28,500 | $156,000 | 0.02% |
| Caprock Group, LLC | 14,085 | $77,000 | 0.02% |